2d
Fintel on MSNEvercore ISI Group Initiates Coverage of Summit Therapeutics (SMMT) with Outperform RecommendationFintel reports that on March 12, 2025, Evercore ISI Group initiated coverage of Summit Therapeutics (NasdaqGM:SMMT) with a ...
3d
Fintel on MSNEvercore ISI Group Upgrades CenterPoint Energy (CNP)Fintel reports that on March 11, 2025, Evercore ISI Group upgraded their outlook for CenterPoint Energy (NYSE:CNP) from ...
In a report released yesterday, David Motemaden from Evercore ISI maintained a Hold rating on Factset Research (FDS – Research Report), with a ...
In a report released yesterday, David Motemaden from Evercore ISI maintained a Hold rating on Arch Capital Group (ACGL – Research Report), with ...
NEW YORK, March 03, 2025--Evercore (NYSE: EVR) announced today that Joe Modisett has joined the firm as a senior managing director in the Healthcare Investment Banking group, based in New York.
Capital One Financial (NYSE:COF) was upgraded by investment analysts at Evercore ISI from an “in-line” rating to an ...
Evercore Group, or Lazard. Increasing Our Fair Value Estimate for Evercore to $166 From $158 Evercore’s revenue and earnings could experience a relatively tough year or two compared with the ...
Oracle (NYSE:ORCL – Get Free Report) had its price target cut by equities researchers at Evercore ISI from $200.00 to $185.00 ...
Evercore (NYSE: EVR) announced today that Joe Modisett has joined the firm as a senior managing director in the Healthcare Investment Banking group, based in New York. Naveen Nataraj, co-head of U ...
today announced that it will attend the Evercore 17th Annual Industrial Conference in New York, New York on Tuesday, March 4, 2025. Print (PRNewsfoto/Montrose Environmental Group, Inc.) ...
Fintel reports that on March 11, 2025, Evercore ISI Group upgraded their outlook for CenterPoint Energy (LSE:0HVF) from In-Line to Outperform. As of March 5, 2025, the average one-year price ...
Fintel reports that on March 12, 2025, Evercore ISI Group initiated coverage of Summit Therapeutics (NasdaqGM:SMMT) with a Outperform recommendation. As of March 4, 2025, the average one-year ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results